COVID-19 Infection | Norton Healthcare

Indication: COVID-19 Infection

Expanded Access to Convalescent Plasma for the Treatment of Patients with COVID-19

Severe or life threatening

Specimen

Principal Investigator: Don Stevens, M.D.
Norton Cancer Institute

Sponsor: Food and Drug Administration (FDA)

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.